Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

| More on:

Young African Businesswoman Analyzing Data On Multiple Computer Screen In Office

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Gold Road Resources Ltd (ASX: GOR)

According to a note out of Goldman Sachs, its analysts have retained their buy rating on this gold miner's shares with a slightly trimmed price target of $1.95. This follows the release of the company's quarterly update. Goldman notes that much of the update was pre-released, so there were not many surprises. And while the wet weather impact has disappointingly led to management guiding to production at the low end of its guidance range and costs at the high end of its guidance range, the broker remains positive. Particularly given its valuation. Goldman highlights that Gold Road's shares are trading at ~0.9x net asset value compared to its peers at 1.3x net asset value. It also has near-term free cash flow yields of 5% to 10% through to FY 2026. The Gold Road share price is trading at $1.61 on Monday.

NextDC Ltd (ASX: NXT)

A note out of Morgans reveals that its analysts have retained their add rating and $19.00 price target on this data centre operator's shares. This follows the completion of the company's institutional entitlement offer which raised $937 million. It believes this leaves NextDC well-positioned for growth over the coming years. Especially as artificial intelligence drives another wave of demand for capacity in data centres. The broker is so positive on the company's outlook that it sees scope for its shares to be trading around the $40 mark at the start of the next decade. For now, the NextDC share price is fetching $15.84 this afternoon.

ResMed Inc. (ASX: RMD)

Another note out of Morgans reveals that its analysts have retained their add rating and $32.82 price target on this sleep disorder treatment company's shares. The broker notes that Eli Lilly & Co (NYSE: LLY) has released positive trial results from its weight loss wonder drug in the treatment of sleep apnoea. However, Morgans doesn't see this as a negative. As well as expecting only a negligible impact on the market, it feels the drugs are likely to support its expansion. As a result, it remains very bullish on the company's outlook. The ResMed share price is trading at $28.00 on Monday.

Motley Fool contributor James Mickleboro has positions in Nextdc and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet
Broker Notes

Why these ASX shares could be top SMSF options in 2025

Analysts are bullish on these high-quality shares. Let's find out why.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX 200 shares could rise 20% to 40% in 2025

Analysts are tipping these shares to deliver huge returns for investors next year.

Read more »

a group of people stand examining a large glowing cystral ball held in the hands of one of the group members while the others regard it with various expressions of wonder, curiousity and scepticism.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Guess which ASX 50 share is a top buy for 2025

Bell Potter has just slapped a buy rating on this stock. Let's see why.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Broker Notes

Goldman Sachs just put a buy rating on this ASX 200 share

The broker has good things to say about this 'high-quality' company.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A little boy holds his fingers to his head posing as a bull.
Broker Notes

Why this broker is bullish on these ASX 200 stocks

Ord Minnett has good things to say about these shares.

Read more »